
The antibacterial drug Avycaz (ceftazidime-avibactam) was given priority review by the Food and Drug Administration (FDA) since new safety data has been discovered.

The antibacterial drug Avycaz (ceftazidime-avibactam) was given priority review by the Food and Drug Administration (FDA) since new safety data has been discovered.

In a matter of weeks, two Texas medical institutions developed the first hospital-based rapid detection Zika test.

A new trial conducted in England has discovered a cost-effective way to reduce the overprescribing of antibiotics by general practitioners (GPs).

When an endoscope-associated outbreak occurred at Virginia Mason Medical Center in Seattle, Washington, officials implemented new practices to avoid it from happening again.

Dr. Jason C. Gallagher, PharmD, Clinical Professor at the Temple University School of Pharmacy describes the difference between antimicrobial and antibiotic resistance.

Jason C. Gallagher, PharmD, explains what healthcare providers can do to help address antibiotic resistance.

An alarmingly high number of blood and bodily fluid exposures go unreported by operating room (OR) nurses in Thailand.

After swabbing 20 beards, more than 100 bacteria growths were identified.

Many vaccine-preventable diseases persist and have increased in prevalence because of lowered immunity in the general population.

There appears to be a positive correlation between higher antibiotic use and the development of type 2 diabetes, according to a study published in The Journal of Clinical Endocrinology & Metabolism.

Reports of measles cases in a suburban Illinois infant care center have added to concerns the preventable but highly contagious illness is spreading.